38 episodes

The cannabis industry is expanding more rapidly than ever before. Hot on its heels is the emerging psychedelics industry. What comes next? Our podcast brings listeners entertaining and insightful discussions with leaders in science, medicine, and health along with their pioneering business counterparts to discuss research and current events.

How to Launch an Industry Marcu & Arora

    • Business
    • 5.0 • 10 Ratings

The cannabis industry is expanding more rapidly than ever before. Hot on its heels is the emerging psychedelics industry. What comes next? Our podcast brings listeners entertaining and insightful discussions with leaders in science, medicine, and health along with their pioneering business counterparts to discuss research and current events.

    Certified Conscious

    Certified Conscious

    We wrap up 2022 with a psychedelics focused episode. Listeners are invited to join the conversation with experts working in legal, standards, research funding, and science aspects of the burgeoning industry.  The episode kicks off with a game about infrastructure and the required picks and shovels for building it.  We then discuss the importance of standards for psychedelics assisted psychotherapy and the launch of a non-profit organization providing leadership in that area.  The episode wraps up with a discussion around indigenous views on the “psychedelics renaissance”, inspired by a recent article published in the journal  Anthropology of Consciousness. 



    Special thanks to the sponsor of this episode the East Fork Cultivars.

    • 1 hr 9 min
    Altered States

    Altered States

    Experts discuss the science of taking the trip out of psychedelics while maintaining the therapeutic benefits, a conversation inspired by a recent article published in Nature. Psychedelics policy is also addressed with a game that tests our guests' knowledge about opposition and support for proposition 122 in Colorado. The show wraps up with a discussion of best practices for performing research on how cannabis may affect the endocannabinoid system.   

    • 1 hr 10 min
    Live from Mendocino

    Live from Mendocino

    Join us for a fun, engaging session where we discuss important issues in cannabis testing, alcohol use, and the psychedelic receptorome. This episode was our first recorded in person, and from the beautiful surroundings of the Mendocino County coast in California.  The group welcomes first time guests, epidemiologist Teresa Simon, MPH and integrative medicine doctor Harry McIlroy, MD.  

    • 1 hr 2 min
    Chemical Co-op

    Chemical Co-op

    This episode starts with a game that tests your knowledge about cannabis sustainability, the environmental impact of hemp operations, and proposed solutions. For our second segment, we discuss reciprocity and sustainability in psychedelics, inspired by an article recently published in Forbes. For our third segment, Rapid Fire Science, we discuss a peer reviewed article, on the serotonin theory of depression, also often referred to as the chemical imbalance theory.

    • 1 hr 25 min
    House of Serotonin

    House of Serotonin

    The group discusses cannabis education, happenings at the FDA, and serotonin syndrome related to psychedelics. There are increasing numbers of universities and colleges offering professional programs and even degrees in cannabis-related areas. Play our game to find the best higher education program for you! In the news segment we dive into surprising big pharma activities with engaging the FDA on cannabis regulations. The show wraps up discussing a review of clinical and mechanistic evidence supporting a hypothesis of potential serotonin related health effects. Join us to learn about cannabinoids, the FDA, and psychedelics.

    • 1 hr 20 min
    Redefining Drug Pipelines

    Redefining Drug Pipelines

    Join us for a conversation about novel drug substances! The topics range from clinical research to the forces within the cannabis industry’s patent and intellectual property issues. In this episode’s game, Dr. Marcu reads clues about cannabis news and political events, and participants have to guess the fake canna-news article. For the news segment, we discuss 18 psychedelics clinical trials that have received significant media attention, and whether they can possibly deliver on the hype. This episode's peer reviewed article is an analysis of the cannabis patent landscape and delves into how common practices may test the limits of the regulated market.

    • 1 hr 3 min

Customer Reviews

5.0 out of 5
10 Ratings

10 Ratings

Vemisery ,

Forward Thinking

I really enjoyed your most recent episode regarding the untapped potential within DMT and Ketamine. Your guest Jocelyn was well informed, and I appreciated her perspectives on the topics that you guys covered. Likely very few people out there have the data-insight within the cannabis industry that she does, and it seems even fewer out there are having discussions on how to use that privilege for a good cause. It’s great to finally hear conversations that may contribute to actually moving the needle when it comes to battling genetic defects, the opiate epidemic and other long-standing human/ego conditions around stigmatized topics like psychedelics as a medicine.

Top Podcasts In Business

Erika Kullberg
Ramsey Network
Freakonomics Network & Zachary Crockett
NPR
Jocko DEFCOR Network
Andy Frisella #100to0